Company intelligence / Profile preview

Exelderm

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~41000
Development stage: Other

Overview

Exelderm is a brand name for sulconazole nitrate, a topical antifungal medication currently marketed by Sun Pharma through its subsidiary Taro Pharmaceuticals. The product is indicated for the treatment of various fungal skin infections, including athlete's foot, jock itch, and ringworm. Sun Pharma is a global specialty pharmaceutical company that manufactures and distributes a wide range of generic and branded formulations across multiple therapeutic areas. The company maintains a significant presence in dermatology, providing various topical treatments for skin conditions.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Exelderm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exelderm.

Explore the full profile